| 000 | 01492 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515005831.0 | ||
| 264 | 0 | _c20060120 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0049-8254 | ||
| 024 | 7 |
_a10.1080/00498250500250493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeinz, C | |
| 245 | 0 | 0 |
_aPharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--in rats and dogs. _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cSep 2005 |
||
| 300 |
_a891-910 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRivaroxaban |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 700 | 1 | _aBuetehorn, U | |
| 700 | 1 | _aDaehler, H-P | |
| 700 | 1 | _aKohlsdorfer, C | |
| 700 | 1 | _aPleiss, U | |
| 700 | 1 | _aSandmann, S | |
| 700 | 1 | _aSchlemmer, K-H | |
| 700 | 1 | _aSchwarz, T | |
| 700 | 1 | _aSteinke, W | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 35 _gno. 9 _gp. 891-910 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00498250500250493 _zAvailable from publisher's website |
| 999 |
_c15931434 _d15931434 |
||